So why in your estimation can they not get this technology up and profitable with all the recent FDA approvals? Is the technology viable or is the CEO just beating a dead horse to continue a salary? Is there buyout value in this product? An honest response of someone familiar with this industry would be appreciated and just not for the sake of bashing